AI assistant
CORCEPT THERAPEUTICS INC — Director's Dealing 2016
Nov 10, 2016
30681_dirs_2016-11-09_a1bdfcda-f98f-4425-9c7e-c20a6755076b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-11-07
Reporting Person: BELANOFF JOSEPH K (Director, CHIEF EXECUTIVE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-07 | Common Stock | M | 93533 | $1.50 | Acquired | 2257728 | Direct |
| 2016-11-07 | Common Stock | S | 93533 | $8.2212 | Disposed | 2164195 | Direct |
| 2016-11-07 | Common Stock | M | 406467 | $1.50 | Acquired | 2570662 | Direct |
| 2016-11-07 | Common Stock | S | 406467 | $8.3244 | Disposed | 2164195 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-07 | Stock Option (Right to Buy) | $1.50 | M | 93533 | Disposed | 2017-04-16 | Common Stock (93533) | Direct |
| 2016-11-07 | Stock Option (Right to Buy) | $1.50 | M | 406467 | Disposed | 2017-04-16 | Common Stock (406467) | Direct |
Footnotes
F1: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.22 to $8.24 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.27 to $8.375 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.
F3: Fully exercisable.